Rapha Capital Management Participates In Series C Financing For Poseida Therapeutics, Inc. Led By Novartis Pharmaceuticals
Rapha Capital Management Participates in Series C Financing for Poseida Therapeutics, Inc. Led by Novartis Pharmaceuticals MIAMI, April 22, 2019-- Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, and their associated entities announced today their participation in a Series C financing for Poseida Therapeutics ("Poseida"). The investment round was led by Novartis Pharma, AG, who were joined by new institutional investors and those with current positions in the company.